Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

All Specialties

OpiCalc Logo
FavoritesSpecialtiesDrugsGuidelinesMost Used
FavesSpecsDrugsGuidesTop
ACMG/AMP Variant ClassifierAmsterdam Criteria IICYP2C19 Phenotype InterpreterDLCN Score (FH)GJB2 Variant InterpreterGhent-2 Criteria (Marfan)HTT CAG Repeat (Huntington)Hereditary Thrombophilia VTE RiskRevised Bethesda GuidelinesTyrer-Cuzick Breast Risk
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2018-2026

•

All Rights Reserved

In Recent Clinical News

Scanning Medical Journals

No new significant updates or guidelines matching this topic were found today. We will check again soon.

Ghent-2 Criteria (Marfan)

Ghent-2 Criteria — Marfan Syndrome

2010 Revised Nosology. Diagnosis requires aortic root Z-score + ectopia lentis, OR FBN1 variant, OR systemic score ≥ 7. Max systemic score = 20.

≥ 2.0 = significant

Ectopia Lentis?

FBN1 Pathogenic Variant Identified?

Systemic Score Features

Score: 0/20
Guidelines & Evidence

Verified

Last Review: 2026

When to Use

When to Use

Diagnosing Marfan syndrome in adults and children (threshold modifications for children < 20yr).
Distinguishing Marfan syndrome from related connective tissue disorders (MASS, MFS1, Loeys-Dietz, EDS-vascular).
Guiding decisions on genetic testing (FBN1 gene sequencing and MLPA).
Endorsed by the International Marfan Foundation, EHN, and incorporated into ESC aortic disease guidelines.

Last Comprehensive Review: 2026